175 related articles for article (PubMed ID: 30099396)
21. Treatment using oxaliplatin and S-1 adjuvant chemotherapy for pathological stage III gastric cancer: a multicenter phase II study (TOSA trial) protocol.
Namikawa T; Maeda H; Kitagawa H; Oba K; Tsuji A; Yoshikawa T; Kobayashi M; Hanazaki K
BMC Cancer; 2018 Feb; 18(1):186. PubMed ID: 29439671
[TBL] [Abstract][Full Text] [Related]
22. Laparoscopy-assisted versus Open D2 Distal Gastrectomy for Advanced Gastric Cancer: Results From a Randomized Phase II Multicenter Clinical Trial (COACT 1001).
Park YK; Yoon HM; Kim YW; Park JY; Ryu KW; Lee YJ; Jeong O; Yoon KY; Lee JH; Lee SE; Yu W; Jeong SH; Kim T; Kim S; Nam BH;
Ann Surg; 2018 Apr; 267(4):638-645. PubMed ID: 28187041
[TBL] [Abstract][Full Text] [Related]
23. A Multi-institutional, Prospective, Phase II Feasibility Study of Laparoscopy-Assisted Distal Gastrectomy with D2 Lymph Node Dissection for Locally Advanced Gastric Cancer (JLSSG0901).
Inaki N; Etoh T; Ohyama T; Uchiyama K; Katada N; Koeda K; Yoshida K; Takagane A; Kojima K; Sakuramoto S; Shiraishi N; Kitano S
World J Surg; 2015 Nov; 39(11):2734-41. PubMed ID: 26170158
[TBL] [Abstract][Full Text] [Related]
24. Laparoscopic total gastrectomy for upper-middle advanced gastric cancer: analysis based on lymph node noncompliance.
Chen QY; Lin GT; Zhong Q; Zheng CH; Li P; Xie JW; Wang JB; Lin JX; Lu J; Cao LL; Huang CM
Gastric Cancer; 2020 Jan; 23(1):184-194. PubMed ID: 31300914
[TBL] [Abstract][Full Text] [Related]
25. Short-term surgical outcomes of laparoscopy-assisted versus open D2 distal gastrectomy for locally advanced gastric cancer in North China: a multicenter randomized controlled trial.
Wang Z; Xing J; Cai J; Zhang Z; Li F; Zhang N; Wu J; Cui M; Liu Y; Chen L; Yang H; Zheng Z; Wang X; Gao C; Wang Z; Fan Q; Zhu Y; Ren S; Zhang C; Liu M; Ji J; Su X
Surg Endosc; 2019 Jan; 33(1):33-45. PubMed ID: 30386984
[TBL] [Abstract][Full Text] [Related]
26. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy versus palliative systemic chemotherapy in stomach cancer patients with peritoneal dissemination, the study protocol of a multicentre randomised controlled trial (PERISCOPE II).
Koemans WJ; van der Kaaij RT; Boot H; Buffart T; Veenhof AAFA; Hartemink KJ; Grootscholten C; Snaebjornsson P; Retel VP; van Tinteren H; Vanhoutvin S; van der Noort V; Houwink A; Hahn C; Huitema ADR; Lahaye M; Los M; van den Barselaar P; Imhof O; Aalbers A; van Dam GM; van Etten B; Wijnhoven BPL; Luyer MDP; Boerma D; van Sandick JW
BMC Cancer; 2019 May; 19(1):420. PubMed ID: 31060544
[TBL] [Abstract][Full Text] [Related]
27. Comparison of SOX and CAPOX in patients with advanced gastric cancer after laparoscopic D2 gastrectomy: A randomized controlled trial.
Liu X; Yan Y; Lu L; Liu Y; Ma J; Wang X; Wang D; Liu B; Liu Z; Zhou X; Cui H; Zhao Z; Li C; Liu J; Li W; Huang QX; Zhao Q; Liu T; Fu W
Cancer Med; 2024 Jun; 13(11):e7326. PubMed ID: 38826114
[TBL] [Abstract][Full Text] [Related]
28. Long-Term Outcomes of Laparoscopic Distal Gastrectomy for Locally Advanced Gastric Cancer: The KLASS-02-RCT Randomized Clinical Trial.
Hyung WJ; Yang HK; Park YK; Lee HJ; An JY; Kim W; Kim HI; Kim HH; Ryu SW; Hur H; Kim MC; Kong SH; Cho GS; Kim JJ; Park DJ; Ryu KW; Kim YW; Kim JW; Lee JH; Han SU;
J Clin Oncol; 2020 Oct; 38(28):3304-3313. PubMed ID: 32816629
[TBL] [Abstract][Full Text] [Related]
29. Five-Year Survival Outcomes of Laparoscopy-Assisted vs Open Distal Gastrectomy for Advanced Gastric Cancer: The JLSSG0901 Randomized Clinical Trial.
Etoh T; Ohyama T; Sakuramoto S; Tsuji T; Lee SW; Yoshida K; Koeda K; Hiki N; Kunisaki C; Tokunaga M; Otsubo D; Takagane A; Misawa K; Kinoshita T; Cho H; Doki Y; Nunobe S; Shiraishi N; Kitano S;
JAMA Surg; 2023 May; 158(5):445-454. PubMed ID: 36920382
[TBL] [Abstract][Full Text] [Related]
30. Comparison of long-term results between laparoscopy-assisted gastrectomy and open gastrectomy with D2 lymph node dissection for advanced gastric cancer.
Hamabe A; Omori T; Tanaka K; Nishida T
Surg Endosc; 2012 Jun; 26(6):1702-9. PubMed ID: 22207307
[TBL] [Abstract][Full Text] [Related]
31. Overview of adjuvant and neoadjuvant therapy for resectable gastric cancer in the East.
Fujitani K
Dig Surg; 2013; 30(2):119-29. PubMed ID: 23867588
[TBL] [Abstract][Full Text] [Related]
32. Four courses versus eight courses of adjuvant S-1 for patients with stage II gastric cancer (JCOG1104 [OPAS-1]): an open-label, phase 3, non-inferiority, randomised trial.
Yoshikawa T; Terashima M; Mizusawa J; Nunobe S; Nishida Y; Yamada T; Kaji M; Fukushima N; Hato S; Choda Y; Yabusaki H; Yoshida K; Ito S; Takeno A; Yasuda T; Kawachi Y; Katayama H; Fukuda H; Boku N; Sano T; Sasako M
Lancet Gastroenterol Hepatol; 2019 Mar; 4(3):208-216. PubMed ID: 30679107
[TBL] [Abstract][Full Text] [Related]
33. Laparoscopic versus open gastrectomy for elderly local advanced gastric cancer patients: study protocol of a phase II randomized controlled trial.
Li Z; Shan F; Ying X; Xue K; Ji J
BMC Cancer; 2018 Nov; 18(1):1118. PubMed ID: 30445943
[TBL] [Abstract][Full Text] [Related]
34. Comparison of short-term outcomes and quality of life in totally laparoscopic distal gastrectomy and totally robotic distal gastrectomy for clinical stage I-III gastric cancer: study protocol for a multi-institutional randomised clinical trial.
Cui H; Cao B; Liu G; Xi H; Chen Z; Liang W; Zhang K; Cui J; Xie T; Deng H; Tang Y; Chen L; Wei B
BMJ Open; 2021 May; 11(5):e043535. PubMed ID: 34035091
[TBL] [Abstract][Full Text] [Related]
35. Laparoscopic versus open distal gastrectomy for advanced gastric cancer: A meta-analysis of randomized controlled trials and high-quality nonrandomized comparative studies.
Chen X; Feng X; Wang M; Yao X
Eur J Surg Oncol; 2020 Nov; 46(11):1998-2010. PubMed ID: 32758382
[TBL] [Abstract][Full Text] [Related]
36. Laparoscopic vs Open Distal Gastrectomy for Locally Advanced Gastric Cancer: Five-Year Outcomes From the CLASS-01 Randomized Clinical Trial.
Huang C; Liu H; Hu Y; Sun Y; Su X; Cao H; Hu J; Wang K; Suo J; Tao K; He X; Wei H; Ying M; Hu W; Du X; Yu J; Zheng C; Liu F; Li Z; Zhao G; Zhang J; Chen P; Li G;
JAMA Surg; 2022 Jan; 157(1):9-17. PubMed ID: 34668963
[TBL] [Abstract][Full Text] [Related]
37. [Neoadjuvant chemoradiotherapy combined with surgery versus direct surgery in the treatment of Siewert type II and III adenocarcinomas of the esophagogastric junction: long-term prognostic analysis of a prospective randomized controlled trial].
Tian Y; Wang Q; Wang J; Qiao XY; Zhang J; Lin YC; Li Y; Fan LQ; Yang PG; Zhao Q
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):128-137. PubMed ID: 33508918
[No Abstract] [Full Text] [Related]
38. Comparison of outcomes for laparoscopically assisted and open radical distal gastrectomy with lymphadenectomy for advanced gastric cancer.
Zhao Y; Yu P; Hao Y; Qian F; Tang B; Shi Y; Luo H; Zhang Y
Surg Endosc; 2011 Sep; 25(9):2960-6. PubMed ID: 21512884
[TBL] [Abstract][Full Text] [Related]
39. Gastrectomy with or without neoadjuvant S-1 plus cisplatin for type 4 or large type 3 gastric cancer (JCOG0501): an open-label, phase 3, randomized controlled trial.
Iwasaki Y; Terashima M; Mizusawa J; Katayama H; Nakamura K; Katai H; Yoshikawa T; Ito S; Kaji M; Kimura Y; Hirao M; Yamada M; Kurita A; Takagi M; Lee SW; Takagane A; Yabusaki H; Hihara J; Boku N; Sano T; Sasako M
Gastric Cancer; 2021 Mar; 24(2):492-502. PubMed ID: 33200303
[TBL] [Abstract][Full Text] [Related]
40. [Safety and effectiveness of oxaliplatin combined with capecitabine or oxaliplatin combined with S-1 neoadjuvant chemotherapy in the treatment of advanced gastric cancer].
Xie BW; Zang L; Ma JJ; Sun J; Yang X; Wang ML; Lu AG; Hu WG; Zheng MH
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):138-144. PubMed ID: 33508919
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
